(2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyridin-4-yl)boronic acid
98%
- Product Code: 89007
CAS:
1003043-73-9
| Molecular Weight: | 307.16 g./mol | Molecular Formula: | C₁₄H₂₂BN₃O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD18261480 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
This chemical is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as the Suzuki-Miyaura reaction. It serves as a key intermediate in the preparation of complex molecules, including pharmaceuticals and biologically active compounds. Its boronic acid group enables efficient coupling with aryl halides, facilitating the construction of carbon-carbon bonds. Additionally, the tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection, enabling further functionalization in multi-step synthetic pathways. This compound is valuable in medicinal chemistry for designing and synthesizing drug candidates with potential therapeutic applications.
Product Specification:
| Test | Specification |
|---|---|
| PURITY | 97.5-100 |
| Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | €971.39 |
+
-
|
(2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)pyridin-4-yl)boronic acid
This chemical is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as the Suzuki-Miyaura reaction. It serves as a key intermediate in the preparation of complex molecules, including pharmaceuticals and biologically active compounds. Its boronic acid group enables efficient coupling with aryl halides, facilitating the construction of carbon-carbon bonds. Additionally, the tert-butoxycarbonyl (Boc) protecting group on the piperazine moiety allows for selective deprotection, enabling further functionalization in multi-step synthetic pathways. This compound is valuable in medicinal chemistry for designing and synthesizing drug candidates with potential therapeutic applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :